21802-37-9
Chemical Structure
Caerulomycin A
Synonym(s): Cerulomycin; Caerulomycin
- CAS No.: 21802-37-9
- Formula:C12H11N3O2
- Molecular Weight:229.24
IUPAC Name: (E)-4-methoxy-[2,2'-bipyridine]-6-carbaldehyde oxime
InChIKey: JCTRJRHLGOKMCF-RIYZIHGNSA-N
SMILES: COC1=CC(C2=NC=CC=C2)=NC(/C=N/O)=C1
Biological Activity: Caerulomycin A is an orally active immunomodulator and antimicrobial agent. Caerulomycin A targets Smad3, STAT1 and GATA-3. Caerulomycin A downregulates GATA-3 expression, inhibits Th2 cell differentiation and Th2 cytokine production, reduces IgE levels, and alleviates pulmonary inflammatory responses and eosinophil infiltration. Caerulomycin A ameliorates collagen-induced arthritis symptoms, reduces joint inflammation and synovitis, and decreases the levels of proinflammatory cytokines in joints. Caerulomycin A inhibits the growth of some filamentous fungi, yeasts and specific bacteria. Caerulomycin A can be used in research related to arthritis and asthma[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Caerulomycin A | 98.0% | Caerulomycin A is an orally active immunomodulator and antimicrobial agent. Caerulomycin A targets Smad3, STAT1 and GATA-3. Caerulomycin A downregulates GATA-3 expression, inhibits Th2 cell differentiation and Th2 cytokine production, reduces IgE levels, and alleviates pulmonary inflammatory responses and eosinophil infiltration. Caerulomycin A ameliorates collagen-induced arthritis symptoms, reduces joint inflammation and synovitis, and decreases the levels of proinflammatory cytokines in joints. Caerulomycin A inhibits the growth of some filamentous fungi, yeasts and specific bacteria. Caerulomycin A can be used in research related to arthritis and asthma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.73
HY-138185Collismycin A -
Similarity Score 0.73
HY-N14422Collismycin B -
Similarity Score 0.70
HY-N14615Pyrisulfoxin A -
Similarity Score 0.67
HY-W004762MeO-bpy -
Similarity Score 0.63
![[2,2':6',2''-Terpyridin]-4'-ol Chemical Structure](//file.medchemexpress.com/product_pic/hy-w081679.gif)
HY-W081679[2,2':6',2''-Terpyridin]-4'-ol -
Similarity Score 0.63
HY-N14951Pyrisulfoxin B -
Similarity Score 0.62
HY-125966AI-4-57 -
Similarity Score 0.61
HY-W2506724'-Methyl-2,2':6',2''-terpyridine -
Similarity Score 0.61
HY-W4564346,6'-Dimethoxy-2,2'-bipyridine -
Explore the MedChemAI to find more analogs
![[2,2':6',2''-Terpyridin]-4'-ol Chemical Structure](http://file.medchemexpress.com/product_pic/hy-w081679.gif)
References
- [1]. Gurram RK, et al. Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs). J Biol Chem. 2014;289(25):17515-17528. [Content Brief]
- [2]. Kujur W, et al. Caerulomycin A inhibits Th2 cell activity: a possible role in the management of asthma. Sci Rep. 2015;5:15396. Published 2015 Oct 20. [Content Brief]
- [3]. FUNK A, et al. Caerulomycin, a new antibiotic from Streptomyces caeruleus Baldacci. I. Production, isolation, assay, and biological properties. Can J Microbiol. 1959 Aug;5:317-21. [Content Brief]
